| |
Latest 10 SEC filings (by transaction date) for RZLT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 28/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $2.55 |
Mar 19/24 | Mar 15/24 | Evans Daron | Indirect Ownership | Common Shares | P - Open market or private purchase | 20,000 | $1.69 |
Mar 18/24 | Mar 14/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 10,000 | $1.88 |
Mar 8/24 | Mar 8/24 | Evans Daron | Direct Ownership | Common Shares | P - Open market or private purchase | 50,000 | $1.93 |
Mar 18/24 | Mar 7/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $1.85 |
Mar 14/24 | Mar 7/24 | Kim Young-Jin | Direct Ownership | Common Shares | P - Open market or private purchase | 36,503 | $1.91 |
Mar 11/24 | Mar 7/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $1.85 |
Feb 28/24 | Feb 26/24 | Elam Nevan C | Direct Ownership | Common Shares | P - Open market or private purchase | 5,000 | $1.68 |
Feb 27/24 | Feb 26/24 | Roberts Brian Kenneth | Direct Ownership | Common Shares | P - Open market or private purchase | 2,000 | $1.70 |
Feb 27/24 | Feb 23/24 | Roberts Brian Kenneth | Direct Ownership | Common Shares | P - Open market or private purchase | 6,000 | $1.69 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RZLT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 28/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $2.55 |
Mar 19/24 | Jul 22/22 | Handok, Inc. | Direct Ownership | Common Shares | P - Open market or private purchase | 3,157,895 | $3.80 |
Mar 19/24 | Oct 15/21 | Handok, Inc. | Direct Ownership | Common Shares | P - Open market or private purchase | 769,231 | $6.50 |
Mar 19/24 | Mar 15/24 | Evans Daron | Indirect Ownership | Common Shares | P - Open market or private purchase | 20,000 | $1.69 |
Mar 18/24 | Mar 14/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 10,000 | $1.88 |
Mar 18/24 | Mar 7/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $1.85 |
Mar 14/24 | Mar 7/24 | Kim Young-Jin | Direct Ownership | Common Shares | P - Open market or private purchase | 36,503 | $1.91 |
Mar 14/24 | Jul 22/22 | Kim Young-Jin | Direct Ownership | Common Shares | P - Open market or private purchase | 78,947 | $3.80 |
Mar 11/24 | Mar 7/24 | Roberts Brian Kenneth | Indirect Ownership | Common Shares | P - Open market or private purchase | 500 | $1.85 |
Mar 8/24 | Mar 8/24 | Evans Daron | Direct Ownership | Common Shares | P - Open market or private purchase | 50,000 | $1.93 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |